1987
DOI: 10.1016/s0022-5347(17)43275-7
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosis and Management of Massive Gastrointestinal Bleeding Owing to Duodenal Metastasis from Renal Cell Carcinoma

Abstract: We report 3 cases in which duodenal metastases from renal cell carcinoma caused massive upper gastrointestinal bleeding. In 2 patients the initial symptom was melena and 1 experienced hematobilia. In 2 patients the diagnosis was not suspected until a hypervascular mass was seen on arteriography and the bleeding was controlled by embolization of the gastroduodenal artery. In the third patient an aorto-enteric fistula was suspected on contrast-enhanced computerized tomography but arteriography showed hypervascul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
13
0

Year Published

1992
1992
2015
2015

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 50 publications
(13 citation statements)
references
References 4 publications
0
13
0
Order By: Relevance
“…Hemostasis of gastrointestinal bleeding occurring due to metastasis or invasion of malignant tumor is hard to manage endoscopically, and data on endoscopic therapy of bleeding from these duodenal lesions are limited. In selected cases, intractable gastrointestinal bleeding can be treated with arterial embolization of tumor-supplying arteries that has been reported to control gastrointestinal bleeding effectively, but there are no long-term follow-up data [17, 18, 19]. However, embolotherapy is only palliative while the tumor develops other collateral vessels and has potential for re-bleeding [20].…”
Section: Discussionmentioning
confidence: 99%
“…Hemostasis of gastrointestinal bleeding occurring due to metastasis or invasion of malignant tumor is hard to manage endoscopically, and data on endoscopic therapy of bleeding from these duodenal lesions are limited. In selected cases, intractable gastrointestinal bleeding can be treated with arterial embolization of tumor-supplying arteries that has been reported to control gastrointestinal bleeding effectively, but there are no long-term follow-up data [17, 18, 19]. However, embolotherapy is only palliative while the tumor develops other collateral vessels and has potential for re-bleeding [20].…”
Section: Discussionmentioning
confidence: 99%
“…The conventional surgical treatment for metastasis in the head of the pancreas is pancreaticoduodenectomy. However, in some cases, partial resection of the duodenum, transarterial catheter embolization or radiation therapy are performed as less invasive treatments to avoid burden to the patients [9, 15]. Treatment for metastatic RCC should be individually tailored, with consideration of the patient's general condition and metastases at other sites.…”
Section: Discussionmentioning
confidence: 99%
“…Patients after radical nephrectomy usually present within a year with recurrence but can present after many years, warranting lifelong surveillance [3] . RCC has the potential to metastasize to almost any site but the most common sites are lung (75%), lymph nodes (36%), bone (20%), liver (18%), adrenal glands, kidney, brain, heart, spleen, intestine and skin [4] . 4% of RCC metastasize to the GI tract and account for 7.1% of all metastatic tumors to the small intestine [4,5] .…”
Section: Discussionmentioning
confidence: 99%
“…RCC has the potential to metastasize to almost any site but the most common sites are lung (75%), lymph nodes (36%), bone (20%), liver (18%), adrenal glands, kidney, brain, heart, spleen, intestine and skin [4] . 4% of RCC metastasize to the GI tract and account for 7.1% of all metastatic tumors to the small intestine [4,5] . The duodenum is the least frequent site of metastasis, with the periampullary region the most common site followed by the duodenal bulb [3] .…”
Section: Discussionmentioning
confidence: 99%